Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Other Operating Expenses (2018 - 2025)

TELA Bio (TELA) has 7 years of Other Operating Expenses data on record, last reported at $13.1 million in Q3 2025.

  • For Q3 2025, Other Operating Expenses changed N/A year-over-year to $13.1 million; the TTM value through Sep 2025 reached $42.5 million, up 71.93%, while the annual FY2024 figure was $7.6 million, 85.56% down from the prior year.
  • Other Operating Expenses reached $13.1 million in Q3 2025 per TELA's latest filing, down from $14.7 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $17.2 million in Q4 2023 and bottomed at -$20000.0 in Q2 2024.
  • Average Other Operating Expenses over 5 years is $10.7 million, with a median of $11.2 million recorded in 2022.
  • Peak YoY movement for Other Operating Expenses: plummeted 100.14% in 2024, then surged 73595.0% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $8.3 million in 2021, then surged by 40.11% to $11.6 million in 2022, then surged by 47.37% to $17.2 million in 2023, then tumbled by 100.12% to -$20000.0 in 2024, then soared by 65705.0% to $13.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $13.1 million in Q3 2025, $14.7 million in Q2 2025, and $14.7 million in Q1 2025.